Business Wire

B-Secur and CSEM Partner to Bring Clinically-Validated Heart Monitoring to Health Wearables

28.7.2026 14:00:00 CEST | Business Wire | Press Release

Share

CSEM, the Swiss-based technology innovation centre, and B-Secur, a leader in advanced biosensing technology, today announced a partnership to bring clinically-validated heart monitoring capability to health wearables.

The collaboration pairs CSEM's 25+ years of leadership in PPG-based vital signs monitoring with B-Secur's multiple FDA-cleared ECG algorithms and analytics, offering device manufacturers and digital health companies a route to integrating more accurate, market-ready heart monitoring into their products — for applications including remote patient monitoring, cardiovascular health, and chronic disease management.

“By combining CSEM’s expertise in photoplethysmography-based vital signs monitoring with B-Secur’s ECG analytics, we are enabling a new class of multimodal sensing solutions that deliver clinically relevant insights. This partnership reflects our commitment to translating cutting-edge sensing and algorithm technologies into real-world healthcare applications.”

Josef Hayoz, Senior Manager Medtech, CSEM

The case for combining PPG and ECG

PPG technology has become a cornerstone of consumer health wearables, enabling continuous monitoring of blood oxygen, heart rate, and heart rate variability. While PPG can reliably flag irregular pulse patterns, its ability to accurately classify specific arrhythmia types, beyond atrial fibrillation, remains limited. This limitation is clinically important, as arrhythmia classification is a key factor in risk assessment and treatment decisions. ECG, the recognised standard for heart rhythm analysis, provides the precision needed to confirm or rule out conditions such as atrial fibrillation and more complex rhythm disorders, including supraventricular, ventricular tachycardias, and premature ventricular contractions (PVCs).

Used together, the two technologies are more powerful than either alone: PPG provides continuous background monitoring and a first line of screening, while ECG delivers high-confidence rhythm analysis when an irregularity is detected. CSEM brings deep expertise in PPG and optical sensing, including PPG design expertise and a broad clinically validated portfolio of licensable vital signs algorithms such as blood pressure, SpO₂, respiratory rate, cardiac arrhythmia detection, and sleep monitoring. B-Secur contributes FDA 510(k)-cleared ECG algorithms and analytics, signal chain design expertise, and end-to-end support for regulatory navigation.

Meeting growing demand in digital health

The partnership addresses a significant and growing market need. The global wearable healthcare devices market is projected to grow from $45 billion in 2025 to nearly $76 billion by 2030, according to MarketsandMarkets, with clinical-grade cardiac monitoring among the key growth drivers.

By offering an integrated PPG and ECG solution, B-Secur and CSEM provide device manufacturers with a route to advanced wearable and remote monitoring solutions that meet both clinical relevance and regulatory requirements with the goal of supporting better patient outcomes.

About B-Secur

B-Secur is an advanced biosensing technology company specialising in medical-grade ECG signal processing and rhythm analysis, with multiple FDA 510(k) clearances and ISO 13485:2016 certification.

About CSEM

CSEM is a Swiss non-profit technology innovation centre developing advanced sensing technologies and clinically validated algorithms for digital health, including PPG, multimodal biosensing, and vital signs monitoring.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260728417542/en/

Contacts

Media Contacts

B-Secur
Corinna Keenan
Corinna.Keenan@b-secur.com

CSEM
Sabina Müller, Media Relations
media@csem.ch

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Brings Flagship Kinexions Conference to India, Showcasing Growing Market Momentum17.11.2026 02:30:00 CET | Press Release

Kinaxis® Inc. (TSX: KXS), a global leader in end-to-end supply chain planning and orchestration, today opened its first-ever Kinexions India conference in Mumbai, highlighting the company's growing presence in the country and India's importance to its global innovation and customer delivery operations. With teams in Chennai and Bangalore supporting product development, engineering, professional services and customer success, India plays an important role in Kinaxis' global operations. The company continues to invest in research and development in India, strengthening its engineering and innovation capabilities to support the next generation of AI and supply chain orchestration technologies. "India plays an important role in how we innovate and support customers around the world," said Razat Gaurav, CEO of Kinaxis. "Bringing Kinexions here for the first time reflects both the strength of India's technology ecosystem and the growing role its enterprises play in shaping global supply chai

Povofortay ® (povorcitinib) Approved in Europe as the First Once-Daily Oral Treatment for Adults with Moderate to Severe Hidradenitis Suppurativa16.11.2026 22:30:00 CET | Press Release

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Povofortay® (povorcitinib) 45 mg and 75 mg for the treatment of eligible adults with moderate to severe hidradenitis suppurativa (HS). “The European Commission approval of Povofortay marks an important milestone for Incyte, advancing a key growth driver for our business and bringing a new treatment option to people living with HS, a chronic and often debilitating disease,” 2,3 said Bill Meury, Chief Executive Officer, Incyte."As the first and only once-daily oral treatment approved in the European Union for eligible adults with moderate to severe HS, Povofortay gives physicians an important new option for their patients.” The approval is based on results from the pivotal STOP-HS1 (NCT05620823) and STOP-HS2 (NCT05620836) trials evaluating the safety and efficacy of Povofortay in patients with moderate to severe HS.2 Data from the Phase 3 STOP-HS program demonstrated Povofortay’s clinically meaningful and

Lattice Extends Space Heritage with On-Orbit Milestone in TESAT Optical Communication Terminals16.11.2026 22:00:00 CET | Press Release

Lattice Semiconductor (NASDAQ: LSCC), the low power programmable and platform firmware leader, today announced that its low power, radiation-resilient Lattice Nexus™ FPGAs have surpassed one year of on-orbit operation in TESAT optical communication terminals. Since launch, the FPGAs have delivered consistent performance in the demanding application of space-based laser communication at 10 Gbps, adding to Lattice’s space heritage of thousands of FPGAs launched to date. TESAT has flown optical communication terminals on GEO and LEO missions for more than a decade, supplying broadband constellations and institutional programs. For the redesign of its terminal electronics, Lattice Nexus FPGAs addressed TESAT’s requirements for radiation tolerance, low power, and board footprint. Built on 28 nm fully depleted silicon-on-insulator (FD-SOI) process technology, the Nexus platform is well suited to a terminal that must run for years without maintenance. “As optical links and onboard processing

Moody’s Names Timothy Bhatt as Chief Information Officer16.11.2026 22:00:00 CET | Press Release

Moody’s Corporation (NYSE: MCO) announced today that it has named Tim Bhatt to the newly created role of Chief Information Officer (CIO), effective December 7th, and that he will join the company’s Executive Leadership Team. Mr. Bhatt, who has served as Chief Technology Officer (CTO) of Moody’s Ratings since 2018, will also continue in that role. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261116893391/en/ Timothy Bhatt, Chief Information Officer, Moody's As CIO, Mr. Bhatt will lead Moody’s enterprise technology strategy, AI enablement, and information security, with responsibility for the company’s technology services and operations and cybersecurity teams. He will further modernize how Moody’s operates, bringing together human expertise, trusted data and AI agents to reimagine enterprise workflows and move AI agents from pilots into everyday work. Mr. Bhatt will also continue as Chief Technology Officer of Moody’s Ratin

New Holiday Data From Xsolla Shows Players Are Shopping, Gifting, and Choosing Brands Inside Video Games16.11.2026 18:00:00 CET | Press Release

Xsolla (USA), Inc., a global commerce company, today announced a new data and insights report on how players shop, spend, and respond to brands during the holiday season. Titled “Why Video Games Belong in Your Holiday Commerce Strategy,” the report draws on direct answers from more than 4,000 players, gathered through opt-in rewarded surveys on Xsolla Offerwall. Players chose to take part and received a reward for sharing, which makes the data first-party and consent-based. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111104582/en/ Graphic: Xsolla The research builds on the conversation Xsolla opened at Advertising Week New York 2026 about how brands can reach players in more ways through video games. Combined with Xsolla’s insights into in-game purchasing behavior across an audience of over 300 million players, the survey shows an engaged audience with established spending habits: 84% of respondents call themselves gam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye